Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Matinas Biopharma Holdings, Inc. (MTNB) had Debt to Capital Ratio of 0.00 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-1.33M |
|
-- |
|
-- |
|
$1.55M |
|
$-1.55M |
|
$0.23M |
|
$-1.33M |
|
$-1.19M |
|
$-1.33M |
|
$-1.33M |
|
$-1.33M |
|
$-1.19M |
|
$-1.55M |
|
$-1.55M |
|
0.43M |
|
0.43M |
|
$-3.15 |
|
$-3.15 |
|
| Balance Sheet Financials | |
$1.14M |
|
-- |
|
$2.27M |
|
$3.41M |
|
$1.35M |
|
$0.01M |
|
$0.26M |
|
$1.61M |
|
$1.80M |
|
$1.80M |
|
$1.80M |
|
0.43M |
|
| Cash Flow Statement Financials | |
$-3.44M |
|
-- |
|
$-0.00M |
|
$4.25M |
|
$0.81M |
|
$-3.44M |
|
$0.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.85 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.00 |
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.44M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-73.67% |
|
-73.67% |
|
-38.86% |
|
-73.46% |
|
$4.21 |
|
$-8.04 |
|
$-8.04 |
|